The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors

R. M. Egeler, J. P. Neglia, M. Arico, B. E. Favara, A. Heitger, M. E. Nesbit, H. S. Nicholson

    Research output: Contribution to journalArticlepeer-review

    157 Scopus citations

    Abstract

    The frequency of Langerhans cell histiocytosis (LCH) and a malignant neoplasm occurring in the same individual appears to be greater than previously recognized. To define the occurrence and the pattern of these events, a Study Group of the Histiocyte Society initiated a registry of patients in whom this association occurred synchronously or asynchronously. Evaluation of 54 patients detected two patterns of associations between LCH and other disorders. First, it is possible that therapy of LCH promotes a secondary malignancy. Second, it is possible that a genetic predisposition, with or without the immunosuppression associated therapy for the malignancy, plays a role in the development and expression of disseminated LCH. Data collected by the LCH-Malignancy Study Group may provide insights into the etiology and pathophysiology of LCH.

    Original languageEnglish (US)
    Pages (from-to)369-378
    Number of pages10
    JournalHematology/Oncology Clinics of North America
    Volume12
    Issue number2
    DOIs
    StatePublished - 1998

    ASJC Scopus subject areas

    • Hematology
    • Oncology

    Fingerprint

    Dive into the research topics of 'The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors'. Together they form a unique fingerprint.

    Cite this